THY1 and breast cancer: For example, in the myCAFs from pancreatic ductal adenocarcinoma (PDAC) the levels of the myCAF marker Thy1 are clearly much higher than in iCAFs and apCAFs [26], but in breast cancer, no significant differences in Thy1 levels are found among the different subtypes [27, 34].